StockData
JUSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Jushi Holdings Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$0.49−0.03 (-5.50%)

Close on Oct 19, 2026

Market cap
$98.11M
P/E (TTM)
–
Dividend yield
–

About Jushi

Medicinal Chemicals & Botanical Products, SIC 2833

The company is a vertically integrated cannabis operator in the United States that cultivates, processes, distributes, and sells cannabis products. Its operations encompass retail dispensaries and wholesale distribution to licensed third parties. The product catalog includes dried flower, pre-rolls, vaporizers, concentrates, infused edibles such as gummies and chocolates, tinctures, capsules, and topicals. It also supplies bulk raw materials to other manufacturers. The company serves both registered medical patients and adult-use recreational consumers.

Geographically, the company maintains operations across eight U.S. states: California, Illinois, Massachusetts, Nevada, New Jersey, Ohio, Pennsylvania, and Virginia. Its retail footprint includes forty-two operational dispensaries, comprising twenty-four medical and eighteen adult-use storefronts primarily under the Beyond Hello, Nature’s Remedy, and NuLeaf banners. The company also operates specialized cultivation and manufacturing facilities in Massachusetts, Nevada, Ohio, Pennsylvania, and Virginia. The provided report does not state the location of the corporate headquarters.

Summary of the business section of Jushi's latest annual report, written by StockData.

Company profile

Company

Legal name
Jushi Holdings Inc.
Headquarters
Boca Raton, FL
Address
301 Yamato Road, Suite 3250 33431
Phone
(561) 617-9100
Employees
1,288, Dec 31, 2025
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
A1
Fiscal year ends
December 31
Auditor
Macias Gini & OConnell LLP, Irvine, California

Stock & identifiers

Ticker
JUSH
Exchange
OTC
Shares outstanding
200M, Jul 21, 2026
Public float
$59.40M, Jun 30, 2025
Filer category
<br>Emerging growth company
SEC CIK
1909747
CUSIP
48214U104
ISIN
US48214U1043
EIN
98-1547061

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
James CacioppoChief Executive Officer, Director16,938,283
Louis Jon BarackPresident2,928,773
Michelle O. MosierChief Financial Officer147,733
Benjamin CrossDirector239,080
Stephen MonroeDirector153,684
Bill WaffordDirector–
Marina HahnDirector17,301

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 1,288 employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Mar 15, 2024Late filingNotification of late filing
Apr 25, 2023Auditor changeChange in certifying accountant (8-K Item 4.01)
Mar 31, 2023Late filingNotification of late filing
Nov 15, 2022Late filingNotification of late filing